CD69 and central nervous system cancer: However, when these mice were rechallenged with glioma cells i.c. on day 60 after the transplantation, the mice treated with αCD69 antibody lost their tumor-rejecting capacity (Fig. 7f, h) indicating that CD69 does not affect the executive function of TRM cells but is required for their prolonged residence and function in brains.